Immunogenicity and safety of heterologous mRNA-1273/MVC-COV1901 vaccination versus homologous mRNA1273 vaccination: A randomized, double-blind controlled study
Journal
Journal of the Formosan Medical Association = Taiwan yi zhi
Date Issued
2023-06-14
Author(s)
Huang, Szu-Ting
Lien, Chia-En
Chen, Charles
Abstract
MVC-COV1901 is a protein vaccine based on the same SARS-CoV-2 strain used in mRNA vaccine mRNA-1273. Data are lacking on immunogenicity and safety of MVC-COV1901 as heterologous boost for people already received one dose of mRNA-1273.
Subjects
COVID-19; Heterologous prime boost; Immunogenicity; Protein-based vaccine; mRNA vaccine
SDGs
Type
journal article